JAKAFI Adverse Event: White blood cell count increased
JAKAFI Adverse Event: White blood cell count increased is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: JAKAFI; Product category: Drug; Primary reaction: White blood cell count increased.
| Primary drug | JAKAFI |
|---|---|
| Product category | Drug |
| Primary reaction | White blood cell count increased |
| All reactions | White blood cell count increased; Gout; Fatigue; Red blood cell count decreased; Muscle spasms |
| Seriousness | Not serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | JAKAFI; JAKAFI; JAKAFI; REVLIMID |
| Reporter country | US |
| Reporter type | 5 |
| Report date | 20140312 |
| Report ID | 10003546 |
$299/mo
Try FDATracker →